Available Forms: Capsules
Available Strengths: 1 g
Reference Brands: Vascepa (USA), Vazkepa (EU/UK)
Category: Heart Disorder
Icosapent ethyl is a highly purified ethyl ester of eicosapentaenoic acid (EPA), an omega-3 fatty acid. It is used alongside statin therapy in adults with elevated triglycerides to reduce the risk of cardiovascular events such as heart attack and stroke. Icosapent Ethyl is available in Capsules and strengths such as 1 g. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Icosapent Ethyl is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Icosapent Ethyl can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Quick Response Guaranteed | Verified Suppliers
Icosapent Ethyl is used to reduce high triglyceride levels and to lower the risk of cardiovascular events such as heart attack and stroke in patients with elevated triglycerides who are already on statin therapy. It contains a purified form of EPA, an omega-3 fatty acid.
It is made from icosapent ethyl, a highly purified ethyl ester of eicosapentaenoic acid (EPA), derived from omega-3 fatty acids.
The commonly known trade name is Vascepa.
Vascepa is marketed by Amarin Pharma.
The generic name is icosapent ethyl.
The well-known brand name is Vascepa.
Icosapent Ethyl is manufactured in several regions including India, the USA, and parts of the EU by branded and authorized generic manufacturers.
Strength: 0.5 mg, 1 mg, 2 mg
Form: Tablets
Reference Brands: Mavik (USA), Gopten (EU)
Strength: 2.5 mg/mL
Form: Injection
Reference Brands: Aggrastat (USA)
Strength: 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg
Form: Tablets / Injection
Reference Brands: Uptravi (USA/EU)
Strength: 15 mg, 30 mg, 60 mg
Reference Brands: Savaysa (USA), Lixiana (EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.